Americana Partners’s Procept Biorobotics PRCT Stock Holding History

Americana Partners’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$353K	Sell	15,650 -7,275	-32%	-$182K	0.01%	451
2026 Q1	$573K	Buy	22,925 +1,500	+7%	+$42.3K	0.01%	337
2025 Q4	$674K	Buy	21,425 +2,000	+10%	+$66.3K	0.02%	302
2025 Q3	$693K	Sell	19,425 -1,400	-7%	-$63.9K	0.02%	288
2025 Q2	$1.2M	Sell	20,825 -1,000	-5%	-$56.5K	0.04%	230
2025 Q1	$1.27M	Sell	21,825 -1,700	-7%	-$116K	0.05%	204
2024 Q4	$1.89M	Buy	23,525 +4,875	+26%	+$416K	0.08%	184
2024 Q3	$1.49M	Buy	+18,650	New	+$1.32M	0.1%	159

Other funds holding PRCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Americana Partners's PRCT Position: Q2 2026 in Review

Americana Partners reduced its Procept Biorobotics (PRCT) stake by 32% in Q2 2026, selling an estimated $182K and leaving 15,650 shares worth $353K. The position accounts for 0.01% of the portfolio, ranked #451.

Americana Partners first reported a position in PRCT in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.89M in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

Americana Partners held 15,650 shares of Procept Biorobotics worth $353K as of Q2 2026.
Americana Partners sold 7,275 Procept Biorobotics shares in Q2 2026, an estimated $182K.
Procept Biorobotics made up 0.01% of Americana Partners's portfolio in Q2 2026, its #451 holding.
Americana Partners first reported a position in Procept Biorobotics in Q3 2024 and has held it in 8 quarters since.
Americana Partners's Procept Biorobotics position peaked at $1.89M in Q4 2024.
254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Americana Partners's 13F filing for Q2 2026, filed 5 Aug 2026.